BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7021793)

  • 1. Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease.
    Manouchehr-Pour M; Spagnuolo PJ; Rodman HM; Bissada NF
    J Periodontol; 1981 Aug; 52(8):410-5. PubMed ID: 7021793
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of novel lipoxygenase products on neutrophil and eosinophil functions in vitro.
    Palmblad J; Udén AM; Friberg I; Ringertz B; Rådmark O; Lindgren JA; Hansson G; Malmsten CL
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():25-31. PubMed ID: 6303087
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotactic deactivation of human neutrophils: relationship to loss of cytotaxin receptor function and temporal nature of the phenomenon.
    Nelson RD; Fiegel VD; Herron MJ; Simmons RL
    J Reticuloendothel Soc; 1980 Sep; 28(3):285-94. PubMed ID: 7411541
    [No Abstract]   [Full Text] [Related]  

  • 4. A possible role for cold insoluble globulin in chemotactic factor mediated polymorphonuclear leukocyte adherence to plastic.
    Spagnuolo PJ; Lederman MM; Schiltz J; Ellner J; Culp L
    Biochem Biophys Res Commun; 1982 May; 106(2):471-8. PubMed ID: 7049175
    [No Abstract]   [Full Text] [Related]  

  • 5. The alterative effect of isobutylmethylxanthine in hypofunctional human neutrophil chemotaxis.
    Debski BF; Ranney RR; Carchman RA
    Biochem Biophys Res Commun; 1982 Oct; 108(3):1228-34. PubMed ID: 6185116
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of granulocyte response to the chemoattractant F-Met-Leu-Phe.
    Dahlgren C; Stendahl O
    Adv Exp Med Biol; 1982; 155():107-12. PubMed ID: 6297266
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotactic stimuli-induced changes in the pHi of rabbit neutrophils.
    Sha'afi RI; Naccache PH; Molski TF; Volpi M
    Kroc Found Ser; 1981; 15():513-25. PubMed ID: 6951955
    [No Abstract]   [Full Text] [Related]  

  • 9. Phloretin is a potent inhibitor of rabbit neutrophil activation by chemotactic factors.
    Shefcyk J; Molski TF; Volpi M; Naccache PH; Sha'afi RI
    Biochim Biophys Acta; 1983 Feb; 728(1):97-102. PubMed ID: 6830775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
    Dahinden C; Fehr J
    J Clin Invest; 1980 Nov; 66(5):884-91. PubMed ID: 7430350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for 5, 12-dihydroxy-6,8,10,14-eicosatetraenoate as a mediator of human neutrophil aggregation.
    O'Flaherty JT; Hammett MJ; Shewmake TB; Wykle RL; Love SH; McCall CE; Thomas MJ
    Biochem Biophys Res Commun; 1981 Nov; 103(2):552-8. PubMed ID: 6277309
    [No Abstract]   [Full Text] [Related]  

  • 12. Demonstration of calcium-dependent chemotactic factor activatable esterase activity in human neutrophils: relationship with chemotaxis and chemotactic deactivation.
    Mehta J; Mandell B; Kleyman T; Spilberg I
    Inflammation; 1981 Jun; 5(2):89-101. PubMed ID: 7275278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo crevicular leukocyte response to a chemotactic challenge: inhibition by experimental diabetes.
    Golub LM; Nicoll GA; Iacono VJ; Ramamurthy NS
    Infect Immun; 1982 Sep; 37(3):1013-20. PubMed ID: 6752017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures.
    Fearon DT; Collins LA
    J Immunol; 1983 Jan; 130(1):370-5. PubMed ID: 6847888
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of human polymorphonuclear leukocyte superoxide release by cellular responses to chemotactic peptides.
    English D; Roloff JS; Lukens JN
    J Immunol; 1981 Jan; 126(1):165-71. PubMed ID: 6256437
    [No Abstract]   [Full Text] [Related]  

  • 16. A monoclonal antibody-inhibiting FMLP-induced chemotaxis of human neutrophils.
    Cotter TG; Keeling PJ; Henson PM
    J Immunol; 1981 Dec; 127(6):2241-5. PubMed ID: 7053244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface-reactive stimuli selectively increase protein phosphorylation in human neutrophils.
    Schneider C; Zanetti M; Romeo D
    FEBS Lett; 1981 May; 127(1):4-8. PubMed ID: 7250373
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Showell HJ; Freer RJ; Becker EL
    J Immunol; 1982 Feb; 128(2):956-62. PubMed ID: 7033385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotaxis of horse polymorphonuclear leukocytes to N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
    Zinkl JG; Brown PD
    Am J Vet Res; 1982 Apr; 43(4):613-6. PubMed ID: 7073083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actin polymerization induced by chemotactic peptide and concanavalin A in rat neutrophils.
    Rao KM; Varani J
    J Immunol; 1982 Oct; 129(4):1605-7. PubMed ID: 6286771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.